Chlorhexidine Gluconate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

47 API Suppliers, 28 USDMF, 9 CEP/COS, 9 JDMF, 7 EU WC, 1 VMF, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

165 FDF Dossiers, 49 FDA Orange Book, 17 Europe, 67 Canada, 9 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;TOPICAL - 4%, SOLUTION;TOPICAL - 2%, TABLET;DENTAL - 2.5MG, SOLUTION;TOPICAL - 2%;70%, SPONGE;TOPICAL - 2%;70% (1.5ML), SPONGE;TOPICAL - 2%;70% (10.5ML), SPONGE;TOPICAL - 2%;70% (1ML), SPONGE;TOPICAL - 2%;70% (26ML), SPONGE;TOPICAL - 2%;70% (3ML), SOLUTION;TOPICAL - 61%;1%, SWAB;TOPICAL - 3.15%;70% (1.6ML), SWAB;TOPICAL - 3.15%;70% (1ML), SWAB;TOPICAL - 3.15%;70% (5.1ML), SWAB;TOPICAL - 2%;70% (0.67ML), SWAB;TOPICAL - 2%;70% (1.75ML), SWAB;TOPICAL - 2%;70% (5.25ML)

RELATED EXCIPIENT COMPANIES

5 Rochem International Inc, 4 SPI Pharma, 2 Seqens, 12 DKSH, 1 Jai Radhe Sales, 2 Nippon Fine Chemical, 1 Pharm-RX Chemical, 3 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 12 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 4 ACG Worldwide, 18 Actylis, 1 Alcedo Pharmachem, 23 BASF, 2 BioSpectra, 1 Clariant, 6 Corel Pharma Chem, 4 Finar, 5 Gangwal Chemicals, 2 Ideal Cures Pvt Ltd, 9 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 1 Lubrizol Life Science Health, 3 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pluviaendo, 1 Qualicaps, 19 Roquette, 16 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

51 Topical, 35 Solubilizers, 32 Parenteral, 31 Thickeners and Stabilizers, 23 Coating Systems & Additives, 19 Film Formers & Plasticizers, 19 Fillers, Diluents & Binders, 11 Surfactant & Foaming Agents, 11 Rheology Modifiers, 11 Controlled & Modified Release, 10 Co-Processed Excipients, 10 Taste Masking, 10 Emulsifying Agents, 8 Empty Capsules, 5 Direct Compression, 5 Chewable & Orodispersible Aids, 5 Lubricants & Glidants, 4 API Stability Enhancers, 4 Granulation, 2 Disintegrants & Superdisintegrants, 1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 22 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 4 Finished Drug Prices

MARKET PLACE

32 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 1 US Exclusivities

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21074 / DOSAGE - SOLUTION;TOPICAL - 61%;1%

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Alcohol(UNII: 3K9958V90M) (Alcohol - UNII:3K9958V90M)	Alcohol	506.3mg in 1
Chlorhexidine Gluconate(UNII: MOR84MUD8E) (Chlorhexidine - UNII:R4KO0DY52L)	Chlorhexidine Gluconate	8.3mg in 1

Inactive Ingredients

Ingredient Name	Solventum US OpCo LLC
Beheneth-10(313S43DM16)
Cetyl Palmitate(5ZA2S6B08X)
Dimethicone(92RU3N3Y1O)
Docosanol(9G1OE216XY)
Glycerin(PDC6A3C0OX)
polyethylene glycol, unspecified(3WJQ0SDW1A)
Squalane(GW89575KF9)
Water(059QF0KO0R)

Drug Product Composition: Chlorhexidine Gluconate